Cell/Tissue Manufacturing Platform from Cellino Attracts $25M in Funding from ARPA-H

Cellino Biotech has received $25m funding from the Advanced Research Projects Agency for Health to support its project developing cassette-based biomanufacturing technology for personalized regenerative medicines. Using an AI-guided, laser-based process, the technology aims to streamline the production of stem cells for treating a range of chronic and age-related conditions, potentially eliminating the need for matched donors and minimizing immune-related complications.